Empower Advisory Group LLC Boosts Stock Position in Balchem Co. (NASDAQ:BCPC)

Empower Advisory Group LLC grew its stake in shares of Balchem Co. (NASDAQ:BCPC) by 1.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 113,427 shares of the basic materials company’s stock after acquiring an additional 1,201 shares during the period. Empower Advisory Group LLC owned 0.35% of Balchem worth $19,963,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the stock. Envestnet Portfolio Solutions Inc. lifted its position in shares of Balchem by 1.5% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company’s stock worth $604,000 after acquiring an additional 59 shares in the last quarter. Inspire Investing LLC lifted its position in shares of Balchem by 2.7% during the third quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company’s stock worth $413,000 after acquiring an additional 62 shares in the last quarter. Hsbc Holdings PLC lifted its position in shares of Balchem by 1.5% during the second quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company’s stock worth $757,000 after acquiring an additional 75 shares in the last quarter. Atomi Financial Group Inc. lifted its position in shares of Balchem by 6.1% during the third quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock worth $295,000 after acquiring an additional 96 shares in the last quarter. Finally, Xponance Inc. lifted its position in shares of Balchem by 5.2% during the second quarter. Xponance Inc. now owns 2,046 shares of the basic materials company’s stock worth $315,000 after acquiring an additional 102 shares in the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on BCPC shares. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th. HC Wainwright upped their price target on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th.

Balchem Trading Down 0.4 %

Balchem stock opened at $177.59 on Thursday. The stock has a market cap of $5.77 billion, a P/E ratio of 47.74, a PEG ratio of 5.33 and a beta of 0.65. Balchem Co. has a fifty-two week low of $120.76 and a fifty-two week high of $186.03. The firm’s fifty day moving average price is $172.43 and its 200-day moving average price is $165.07. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.